Great product, positive results, saves lives (not a hard sell), huge domestic market, recurring revenue, invaluable media coverage, government funded... Everything is right there, it's a no-brainer.
Yet, with all of these tailwinds, management is simply unable to run a profitable business. The company should be taken private and fixed. It needs a leader whose livelihood depends on its profit. In six months, it'd be worth 5-10x its current share price. So much potential is just being squandered.
- Forums
- ASX - By Stock
- SP3
- SP3 Media thread
SP3 Media thread, page-115
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SP3 (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.6¢ |
Change
-0.001(5.88%) |
Mkt cap ! $4.783M |
Open | High | Low | Value | Volume |
1.6¢ | 1.6¢ | 1.6¢ | $1.6K | 100K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 60000 | 1.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.6¢ | 22775 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 60000 | 0.015 |
1 | 142857 | 0.014 |
3 | 2298461 | 0.013 |
1 | 80000 | 0.012 |
3 | 250001 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 22775 | 1 |
0.017 | 23075 | 1 |
0.018 | 73088 | 1 |
0.019 | 660000 | 1 |
0.020 | 1286181 | 2 |
Last trade - 12.03pm 12/11/2024 (20 minute delay) ? |
Featured News
SP3 (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online